Robert Platt, University of Toronto

Research

Benefit/Harms Diabetes Drug Safety Glp-1 Receptor Agonists Infant Outcomes Maternal Health Obesity Pharmacoepidemiology

Latest funding

The evaluating Glucagon-like peptide-1 Receptor agonists use and pregnancy Outcomes among reproductive-aged Women (GROW) Study
CIHR · 2026 · Principal investigator
$386,326
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
CIHR · 2025 · Co-investigator
$1,268,322
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
CIHR · 2023 · Co-investigator
$100,000

The evaluating Glucagon-like peptide-1 Receptor agonists use and pregnancy Outcomes among reproductive-aged Women (GROW) Study

Principal investigatorCIHR2026Project Grant

Principal investigators: Grandi, Sonia; Hutcheon, Jennifer A; Platt, Robert W; Ray, Joel G

Keywords: Benefit/Harms; Diabetes; Drug Safety; Glp-1 Receptor Agonists; Infant Outcomes; Maternal Health; Obesity; Pharmacoepidemiology; Population-Based Data; Pregnancy

$386,326

BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)

Co-investigatorCIHR2025Project Grant

Principal investigators: Grandi, Sonia; Longo, Cristina M

Keywords: Biologics; Child Outcomes; Drug Effectiveness; Drug Safety; Infant Outcomes; Maternal Health; Pharmacoepidemiology; Population-Based Data; Pregnancy

$1,268,322

BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)

Co-investigatorCIHR2023Pro. Gr.- PA: Human Development Child and Youth Health - Early Career Support

Principal investigators: Grandi, Sonia; Longo, Cristina M

Keywords: Biologics; Child Outcomes; Drug Effectiveness; Drug Safety; Infant Outcomes; Maternal Health; Pharmacoepidemiology; Population-Based Data; Pregnancy

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2026

Subject: Prospective PhD student: Benefit/Harms Dear Professor Platt, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on benefit/harms connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "The evaluating Glucagon-like peptide-1 Receptor agonists use and pregnancy Outcomes among reproductive-aged Women (GROW) Study" (2026), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]